← Back to Search

Other

Blueberry Powder for Infant Development

N/A
Recruiting
Led By Minghua Tang, PhD
Research Sponsored by University of Colorado, Denver
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Willing to consume blueberry/placebo powder
Generally healthy
Timeline
Screening 3 weeks
Treatment Varies
Follow Up over 7 months
Awards & highlights

Study Summary

This trial will study the effects of blueberries on gut microbiota, inflammation and immunity in breastfed infants.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
You are willing to take either the blueberry powder or a placebo powder.
Select...
You are in good overall health.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~over 7 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and over 7 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Dietary Intake
Fecal Calprotectin
Gut Microbiome Composition Analyzed using 16S rRNA Amplicon Sequencing
+6 more
Secondary outcome measures
Blueberry-Specific Food Signatures (Compounds) as Assessed by Metabolomics Analysis

Trial Design

2Treatment groups
Experimental Treatment
Placebo Group
Group I: Intervention GroupExperimental Treatment1 Intervention
Participants will be provided pre-made whole blueberry freeze-dried powder to be consumed.
Group II: Placebo GroupPlacebo Group1 Intervention
Participants will be provided placebo powder to be consumed.

Find a Location

Who is running the clinical trial?

University of Colorado, DenverLead Sponsor
1,726 Previous Clinical Trials
2,141,538 Total Patients Enrolled
1 Trials studying Infant Development
30 Patients Enrolled for Infant Development
U.S. Highbush Blueberry CouncilOTHER
17 Previous Clinical Trials
911 Total Patients Enrolled
Minghua Tang, PhDPrincipal InvestigatorUniversity of Colorado Denver | Anschutz
3 Previous Clinical Trials
205 Total Patients Enrolled
1 Trials studying Infant Development
30 Patients Enrolled for Infant Development

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are researchers currently accepting participants for this investigation?

"Clinicaltrials.gov data reveals that this investigation is currently recruiting participants. It was initially advertised on the 1st of September 2021 and its latest update occurred a week later, on the 8th day of that month."

Answered by AI

What is the current scope of participation in this scientific experiment?

"Affirmative. Clinicaltrials.gov has the latest information on this trial, which was published for public scrutiny on September 1st 2021 and updated lastly on the 8th of same month; it is presently recruiting 152 patients from a single facility."

Answered by AI

What are the eligibility criteria for participation in this clinical investigation?

"This clinical trial will admit 152 infants aged 4-5 Months. The primary requirements for eligibility are general health, term birth (37 weeks or beyond), and the willingness to consume blueberry/placebo powder."

Answered by AI

Does this research protocol include participants aged thirty and above?

"To qualify for this trial, potential participants must be between 4 and 5 months old. For minors aged 18 or younger, there are 26 studies available; additionally, 6 other trials have been designed for seniors who are 65 years of age or older."

Answered by AI
~43 spots leftby Mar 2025